Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity.

作者: C. J. Danpure , P. R. Jennings , P. Fryer , P. E. Purdue , J. Allsop

DOI: 10.1007/BF00711363

关键词:

摘要: Primary hyperoxaluria type 1 (PH1) is an autosomal recessive disease caused by a deficiency of the liver-specific peroxisomal enzyme alanine: glyoxylate aminotransferase (AGT). The notable for its extensive heterogeneity at clinical, biochemical, enzymic and molecular genetic levels. A study 116 PH1 patients over past 8 years has revealed four main phenotypes: (1) absence both AGT catalytic activity immunoreactive protein (≈40% patients); (2) but presence (≈16% (3) (≈41% patients), in most which cases mistargeted to mitochondria instead peroxisomes; (4) variation mistargeting phenotype equally distributed between peroxisomes mitochondria, that aggregated into matrical core-like structures (≈3% patients). Various point mutations, all occurring conserved positions coding regions gene, have been identified these patients. five mutations discussed present study, found individuals manifesting major phenotypes, account expressed alleles about half Caucasian common mutation so far leads Gly170 → Arg amino acid substitution. This mutation, combination with normally Pro11 Leu polymorphism, appears be responsible unprecedented peroxisome-to-mitochondrion phenotype.

参考文章(29)
Dorothy A. Gibbs, R. W. E. Watts, The action of pyridoxine in primary hyperoxaluria. Clinical Science. ,vol. 38, pp. 277- 286 ,(1970) , 10.1042/CS0380277
K. M. Guttridge, S. Griffiths, P. Fryer, P. E. Purdue, N. O. Davidson, S. M. Mauer, M. J. Lumb, P. R. Jennings, C. J. Danpure, J. Allsop, J. I. Scheinman, Enzymological and mutational analysis of a complex primary hyperoxaluria type 1 phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting and intraperoxisomal aggregation. American Journal of Human Genetics. ,vol. 53, pp. 417- 432 ,(1993)
G. von Heijne, Mitochondrial targeting sequences may form amphiphilic helices. The EMBO Journal. ,vol. 5, pp. 1335- 1342 ,(1986) , 10.1002/J.1460-2075.1986.TB04364.X
S. Yokota, T. Oda, A. Ichiyama, Immunocytochemical localization of serine: pyruvate aminotransferase in peroxisomes of the human liver parenchymal cells. Histochemistry and Cell Biology. ,vol. 87, pp. 601- 606 ,(1987) , 10.1007/BF00492477
Kozo Nishiyama, Tsuneyoshi Funai, Ritsuko Katafuchi, Fumitada Hattori, Kaoru Onoyama, Arata Ichiyama, Primary hyperoxaluria type I due to a point mutation of T to C in the coding region of the serine:pyruvate aminotransferase gene. Biochemical and Biophysical Research Communications. ,vol. 176, pp. 1093- 1099 ,(1991) , 10.1016/0006-291X(91)90396-O
C. J. Danpure, Recent advances in the understanding, diagnosis and treatment of primary hyperoxaluria type 1. Journal of Inherited Metabolic Disease. ,vol. 12, pp. 210- 224 ,(1989) , 10.1007/BF01800727
R. W. E. Watts, C. J. Danpure, L. De Pauw, C. Toussaint, , Combined Liver–Kidney and Isolated Liver Transplantations for Primary Hyperoxaluria Type 1: The European Experience Nephrology Dialysis Transplantation. ,vol. 6, pp. 502- 511 ,(1991) , 10.1093/NDT/6.7.502
Christopher J. Danpure, Molecular and Clinical Heterogeneity in Primary Hyperoxaluria Type 1 American Journal of Kidney Diseases. ,vol. 17, pp. 366- 369 ,(1991) , 10.1016/S0272-6386(12)80624-X